NINGBO INNO PHARMCHEM CO.,LTD. highlights the role of N-Boc-D-Serine (CAS 6368-20-3) as a specialty amino acid that significantly optimizes drug synthesis pathways. Its protected functional groups and specific chirality make it an invaluable building block for creating complex pharmaceutical compounds, thereby enhancing the efficiency and success rates of drug development. As a premier pharmaceutical intermediates supplier, we focus on providing these performance-enhancing materials.

N-Boc-D-Serine is a protected derivative of D-serine, a non-proteinogenic amino acid. Its protected nature, featuring the tert-butyloxycarbonyl (Boc) group on the amine, allows for selective chemical modifications. This characteristic is critically leveraged in its application as an N-Boc-D-Serine intermediate for Lacosamide synthesis. Lacosamide, an important anticonvulsant medication, requires precise synthetic steps where the Boc protection on N-Boc-D-Serine ensures the desired reaction outcomes. The meticulous control over CAS 6368-20-3 synthesis is key to achieving this precision.

The use of N-Boc-D-Serine as a high purity chiral amino acid derivative is not limited to Lacosamide. It is widely employed in peptide synthesis, where accurate amino acid sequencing and protection strategies are essential for creating biologically active peptides. Researchers and manufacturers looking to buy N-Boc-D-Serine online value its consistent quality, including its assay of ≥98.0% and low impurity levels, which are crucial for reproducible results in complex multi-step syntheses. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted provider of such high-quality specialty amino acids.

The physical attributes of N-Boc-D-Serine, such as its typical white to off-white powder form and specific melting point range, are indicators of its purity and suitability for pharmaceutical use. By providing this essential specialty amino acid, NINGBO INNO PHARMCHEM CO.,LTD. supports the pharmaceutical industry in streamlining synthesis processes, reducing development timelines, and ultimately bringing safer and more effective medications to patients. Our commitment extends to ensuring a reliable supply of these critical building blocks for pharmaceutical innovation.